Report post
As investors eye potential gains in biotech, industry experts offer insights. Wedbush's Laura Chico highlights 5 top biotech stocks to watch in 2024, while Cramer suggests a stock could soar to over $100 billion with FDA approval. With under-the-radar bets, investors should consider both risks and opportunities in this dynamic sector.

The World's Leading Crypto Trading Platform

Get my welcome gifts